Coya Therapeutics, Inc. Total Contract Liability
Coya Therapeutics, Inc. (COYA) had Total Contract Liability of $1.75 billion as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities
us-gaap:ContractWithCustomerLiability · last filed 2026-08-11
- 2026-06-30: Contract with Customer, Liability $1.75B.
- 2026-03-31: Contract with Customer, Liability $2.00B.
- 2025-12-31: Contract with Customer, Liability $2.25B; Contract with Customer, Liability as first filed $2.25M.
- 2025-09-30: Contract with Customer, Liability $2.01M.
| Period end | Contract with Customer, Liability | Contract with Customer, Liability as first filed |
|---|---|---|
| 2026-06-30 | $1.75B 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $2.00B 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $2.25B 10-Q · filed 2026-08-11 | $2.25M 10-K · filed 2026-03-16 |
| 2025-09-30 | $2.01M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $1.37M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $1.54M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $1.79B 10-Q · filed 2026-08-11 | $1.79M 10-K · filed 2025-03-18 |
| 2023-12-31 | $1.50M 10-K · filed 2026-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |